• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMERIEUX, INC VITEK® 2 AST-YS07 TEST KIT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMERIEUX, INC VITEK® 2 AST-YS07 TEST KIT Back to Search Results
Catalog Number 414967
Device Problem Incorrect Or Inadequate Test Results (2456)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Type  malfunction  
Event Description
A customer from (b)(6) reported to biomérieux a false susceptible fluconazole result for a candida albicans strain from a patient blood culture sample, in association with the vitek® 2 ast-ys07 test kit.The customer reported the initial fluconazole result with the ast-ys07 card was susceptible (mic =4 mg/l).The strain was sent to a reference lab and the result was resistant (mic>= 64¿g/ml) for fluconazole.There was no retest performed on the ast-ys07 card.The customer stated the false susceptible result was reported to the physician, was then corrected following lab reports from the reference lab.There is no indication or report from the hospital or treating physician to biomérieux that the discrepant result led to any adverse event related to the patient's state of health.A biomérieux internal investigation will be initiated.
 
Manufacturer Narrative
A customer from (b)(6) had reported to biomérieux a false susceptible fluconazole result for a candida albicans strain in association with the vitek® 2 ast-ys07 test kit.The customer reported the initial fluconazole result with the ast-ys07 card was susceptible (mic =4 mg/l).The strain was sent to a reference lab, and the result was resistant (mic>= 64 g/ml) for fluconazole.There was no retest performed on the ast-ys07 card.An internal biomérieux investigation was performed using the isolate submitted by the customer.This investigation was initiated due to discrepant fluconazole (flu) results for candida albicans in association with vitek® 2 ast-ys07 and ast-ys08 cards.For the vitek 2 ast ys07 test kit (the subject of this report), investigational testing included: - identification of the isolate was confirmed as candida albicans.- broth microdilution (bmd), the reference method used for the development of fluconazole, obtained a flu result mic
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITEK® 2 AST-YS07 TEST KIT
Type of Device
VITEK® 2 AST-YS07 TEST KIT
Manufacturer (Section D)
BIOMERIEUX, INC
595 anglum road
st. louis MO 63042
Manufacturer (Section G)
BIOMERIEUX, INC
595 anglum road
st. louis MO 63042
Manufacturer Contact
ellen weltmer
595 anglum road
st. louis, MO 63042
3147317301
MDR Report Key7096329
MDR Text Key95764192
Report Number1950204-2017-00435
Device Sequence Number1
Product Code NGZ
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
K133817
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 05/14/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/07/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/05/2018
Device Catalogue Number414967
Device Lot Number2870283203
Other Device ID Number03573026426873
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received04/17/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/06/2017
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-